nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—CYP2C9—brain cancer	0.331	1	CbGaD
Dexamethasone—CYP1B1—Procarbazine—brain cancer	0.188	0.45	CbGbCtD
Dexamethasone—CYP2D6—Lomustine—brain cancer	0.0259	0.0618	CbGbCtD
Dexamethasone—ABCC2—Carboplatin—brain cancer	0.0242	0.0579	CbGbCtD
Dexamethasone—ABCG2—Carboplatin—brain cancer	0.0219	0.0524	CbGbCtD
Dexamethasone—ABCC2—Etoposide—brain cancer	0.0204	0.0486	CbGbCtD
Dexamethasone—PTGS2—Etoposide—brain cancer	0.0201	0.0481	CbGbCtD
Dexamethasone—CYP2D6—Hydroxyurea—brain cancer	0.0196	0.0469	CbGbCtD
Dexamethasone—CYP3A4—Temozolomide—brain cancer	0.0194	0.0462	CbGbCtD
Dexamethasone—ABCG2—Etoposide—brain cancer	0.0184	0.044	CbGbCtD
Dexamethasone—CYP3A4—Lomustine—brain cancer	0.0165	0.0393	CbGbCtD
Dexamethasone—CYP2E1—Etoposide—brain cancer	0.0131	0.0314	CbGbCtD
Dexamethasone—CYP3A5—Etoposide—brain cancer	0.0102	0.0244	CbGbCtD
Dexamethasone—CYP2C8—Etoposide—brain cancer	0.0098	0.0234	CbGbCtD
Dexamethasone—ABCB1—Etoposide—brain cancer	0.00664	0.0159	CbGbCtD
Dexamethasone—CYP3A4—Etoposide—brain cancer	0.00398	0.0095	CbGbCtD
Dexamethasone—PLA2G1B—blood vessel—brain cancer	0.00188	0.0398	CbGeAlD
Dexamethasone—Fluocinonide—SMO—brain cancer	0.00156	1	CrCbGaD
Dexamethasone—NR0B1—gonad—brain cancer	0.00107	0.0226	CbGeAlD
Dexamethasone—NR0B1—pituitary gland—brain cancer	0.00104	0.0221	CbGeAlD
Dexamethasone—CYP3A43—endocrine gland—brain cancer	0.000973	0.0206	CbGeAlD
Dexamethasone—NR3C2—hindbrain—brain cancer	0.000887	0.0188	CbGeAlD
Dexamethasone—PGR—blood vessel—brain cancer	0.000865	0.0183	CbGeAlD
Dexamethasone—PGR—hindbrain—brain cancer	0.000825	0.0175	CbGeAlD
Dexamethasone—NR0B1—endocrine gland—brain cancer	0.000807	0.0171	CbGeAlD
Dexamethasone—PLA2G1B—pituitary gland—brain cancer	0.000742	0.0157	CbGeAlD
Dexamethasone—ANXA1—telencephalon—brain cancer	0.000697	0.0148	CbGeAlD
Dexamethasone—CYP4A11—endocrine gland—brain cancer	0.000694	0.0147	CbGeAlD
Dexamethasone—ANXA1—gonad—brain cancer	0.000582	0.0123	CbGeAlD
Dexamethasone—NR0B1—brain—brain cancer	0.000577	0.0122	CbGeAlD
Dexamethasone—PLA2G1B—endocrine gland—brain cancer	0.000575	0.0122	CbGeAlD
Dexamethasone—PLA2G1B—head—brain cancer	0.000567	0.012	CbGeAlD
Dexamethasone—ANXA1—pituitary gland—brain cancer	0.000567	0.012	CbGeAlD
Dexamethasone—ANXA1—medulla oblongata—brain cancer	0.000547	0.0116	CbGeAlD
Dexamethasone—Skin exfoliation—Hydroxyurea—brain cancer	0.000543	0.00536	CcSEcCtD
Dexamethasone—Petechiae—Temozolomide—brain cancer	0.00054	0.00533	CcSEcCtD
Dexamethasone—Extravasation—Carmustine—brain cancer	0.000526	0.0052	CcSEcCtD
Dexamethasone—CYP17A1—gonad—brain cancer	0.000521	0.011	CbGeAlD
Dexamethasone—PLA2G1B—central nervous system—brain cancer	0.000518	0.011	CbGeAlD
Dexamethasone—Alopecia—Lomustine—brain cancer	0.000513	0.00507	CcSEcCtD
Dexamethasone—NR3C2—brainstem—brain cancer	0.000508	0.0108	CbGeAlD
Dexamethasone—Pulmonary oedema—Hydroxyurea—brain cancer	0.000506	0.005	CcSEcCtD
Dexamethasone—Amenorrhoea—Temozolomide—brain cancer	0.000505	0.00499	CcSEcCtD
Dexamethasone—ANXA1—midbrain—brain cancer	0.0005	0.0106	CbGeAlD
Dexamethasone—CYP17A1—medulla oblongata—brain cancer	0.000491	0.0104	CbGeAlD
Dexamethasone—Leukocytosis—Carmustine—brain cancer	0.000489	0.00483	CcSEcCtD
Dexamethasone—ANXA1—spinal cord—brain cancer	0.000488	0.0104	CbGeAlD
Dexamethasone—CYP11A1—gonad—brain cancer	0.000485	0.0103	CbGeAlD
Dexamethasone—Herpes simplex—Temozolomide—brain cancer	0.000482	0.00476	CcSEcCtD
Dexamethasone—NR3C1—hindbrain—brain cancer	0.000476	0.0101	CbGeAlD
Dexamethasone—Infection—Carboplatin—brain cancer	0.000469	0.00463	CcSEcCtD
Dexamethasone—PTGS2—endothelium—brain cancer	0.000468	0.00993	CbGeAlD
Dexamethasone—CYP11A1—medulla oblongata—brain cancer	0.000456	0.00968	CbGeAlD
Dexamethasone—Necrosis—Etoposide—brain cancer	0.000453	0.00447	CcSEcCtD
Dexamethasone—NR3C2—telencephalon—brain cancer	0.000451	0.00957	CbGeAlD
Dexamethasone—Sweating increased—Procarbazine—brain cancer	0.000449	0.00444	CcSEcCtD
Dexamethasone—ABCB11—endocrine gland—brain cancer	0.000447	0.00948	CbGeAlD
Dexamethasone—Tingling sensation—Etoposide—brain cancer	0.000442	0.00437	CcSEcCtD
Dexamethasone—ANXA1—endocrine gland—brain cancer	0.00044	0.00932	CbGeAlD
Dexamethasone—Skin exfoliation—Carmustine—brain cancer	0.000439	0.00434	CcSEcCtD
Dexamethasone—CYP3A7—endocrine gland—brain cancer	0.000437	0.00927	CbGeAlD
Dexamethasone—ANXA1—head—brain cancer	0.000434	0.0092	CbGeAlD
Dexamethasone—PTGS2—blood vessel—brain cancer	0.000432	0.00915	CbGeAlD
Dexamethasone—Dermatitis bullous—Hydroxyurea—brain cancer	0.000432	0.00427	CcSEcCtD
Dexamethasone—Neuropathy—Carmustine—brain cancer	0.000431	0.00426	CcSEcCtD
Dexamethasone—Skin exfoliation—Temozolomide—brain cancer	0.000424	0.00419	CcSEcCtD
Dexamethasone—Neuropathy—Temozolomide—brain cancer	0.000417	0.00412	CcSEcCtD
Dexamethasone—PLA2G1B—brain—brain cancer	0.000411	0.00872	CbGeAlD
Dexamethasone—Dry eye—Temozolomide—brain cancer	0.00041	0.00405	CcSEcCtD
Dexamethasone—Infection—Lomustine—brain cancer	0.00041	0.00405	CcSEcCtD
Dexamethasone—Extravasation—Etoposide—brain cancer	0.000407	0.00402	CcSEcCtD
Dexamethasone—Thrombocytopenia—Lomustine—brain cancer	0.000404	0.00399	CcSEcCtD
Dexamethasone—Pain—Carboplatin—brain cancer	0.000403	0.00399	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Procarbazine—brain cancer	0.000403	0.00398	CcSEcCtD
Dexamethasone—ANXA1—central nervous system—brain cancer	0.000396	0.0084	CbGeAlD
Dexamethasone—CYP17A1—endocrine gland—brain cancer	0.000394	0.00835	CbGeAlD
Dexamethasone—Anorexia—Lomustine—brain cancer	0.000393	0.00389	CcSEcCtD
Dexamethasone—CYP17A1—head—brain cancer	0.000389	0.00824	CbGeAlD
Dexamethasone—ANXA1—cerebellum—brain cancer	0.000387	0.00821	CbGeAlD
Dexamethasone—SLCO1A2—telencephalon—brain cancer	0.000387	0.0082	CbGeAlD
Dexamethasone—Thrombophlebitis—Carmustine—brain cancer	0.000385	0.00381	CcSEcCtD
Dexamethasone—Diabetes mellitus—Carmustine—brain cancer	0.000383	0.00379	CcSEcCtD
Dexamethasone—Ulcer—Etoposide—brain cancer	0.000376	0.00371	CcSEcCtD
Dexamethasone—Body temperature increased—Carboplatin—brain cancer	0.000373	0.00369	CcSEcCtD
Dexamethasone—Thrombophlebitis—Temozolomide—brain cancer	0.000372	0.00368	CcSEcCtD
Dexamethasone—Haemoglobin—Procarbazine—brain cancer	0.000371	0.00366	CcSEcCtD
Dexamethasone—Eye pain—Carmustine—brain cancer	0.000369	0.00365	CcSEcCtD
Dexamethasone—Haemorrhage—Procarbazine—brain cancer	0.000369	0.00364	CcSEcCtD
Dexamethasone—NR3C2—pituitary gland—brain cancer	0.000367	0.00779	CbGeAlD
Dexamethasone—Hallucination—Procarbazine—brain cancer	0.000367	0.00363	CcSEcCtD
Dexamethasone—CYP11A1—endocrine gland—brain cancer	0.000366	0.00777	CbGeAlD
Dexamethasone—Injury—Carmustine—brain cancer	0.000363	0.00359	CcSEcCtD
Dexamethasone—CYP11A1—head—brain cancer	0.000362	0.00767	CbGeAlD
Dexamethasone—Decreased appetite—Lomustine—brain cancer	0.000359	0.00355	CcSEcCtD
Dexamethasone—Eye pain—Temozolomide—brain cancer	0.000357	0.00353	CcSEcCtD
Dexamethasone—CYP17A1—central nervous system—brain cancer	0.000355	0.00753	CbGeAlD
Dexamethasone—NR3C2—medulla oblongata—brain cancer	0.000355	0.00752	CbGeAlD
Dexamethasone—CYP2D6—hindbrain—brain cancer	0.000354	0.00751	CbGeAlD
Dexamethasone—CYP1B1—telencephalon—brain cancer	0.000353	0.00748	CbGeAlD
Dexamethasone—PGR—pituitary gland—brain cancer	0.000342	0.00724	CbGeAlD
Dexamethasone—Skin exfoliation—Etoposide—brain cancer	0.000339	0.00335	CcSEcCtD
Dexamethasone—Neuropathy—Etoposide—brain cancer	0.000334	0.0033	CcSEcCtD
Dexamethasone—CYP11A1—central nervous system—brain cancer	0.00033	0.007	CbGeAlD
Dexamethasone—Arrhythmia—Procarbazine—brain cancer	0.000329	0.00326	CcSEcCtD
Dexamethasone—Body temperature increased—Lomustine—brain cancer	0.000326	0.00322	CcSEcCtD
Dexamethasone—Alopecia—Procarbazine—brain cancer	0.000326	0.00322	CcSEcCtD
Dexamethasone—Oesophagitis—Etoposide—brain cancer	0.000325	0.00321	CcSEcCtD
Dexamethasone—Weight increased—Hydroxyurea—brain cancer	0.000324	0.00321	CcSEcCtD
Dexamethasone—NR3C2—midbrain—brain cancer	0.000324	0.00687	CbGeAlD
Dexamethasone—Affect lability—Temozolomide—brain cancer	0.000317	0.00314	CcSEcCtD
Dexamethasone—NR3C2—spinal cord—brain cancer	0.000316	0.0067	CbGeAlD
Dexamethasone—CYP19A1—gonad—brain cancer	0.000315	0.00668	CbGeAlD
Dexamethasone—ANXA1—brain—brain cancer	0.000314	0.00667	CbGeAlD
Dexamethasone—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000312	0.00308	CcSEcCtD
Dexamethasone—Mood swings—Temozolomide—brain cancer	0.000305	0.00302	CcSEcCtD
Dexamethasone—SLCO1A2—medulla oblongata—brain cancer	0.000304	0.00644	CbGeAlD
Dexamethasone—Hypokalaemia—Carmustine—brain cancer	0.000303	0.003	CcSEcCtD
Dexamethasone—Dry skin—Temozolomide—brain cancer	0.000295	0.00292	CcSEcCtD
Dexamethasone—CYP1B1—gonad—brain cancer	0.000294	0.00624	CbGeAlD
Dexamethasone—Muscular weakness—Carmustine—brain cancer	0.000294	0.00291	CcSEcCtD
Dexamethasone—Hypokalaemia—Temozolomide—brain cancer	0.000293	0.0029	CcSEcCtD
Dexamethasone—Syncope—Procarbazine—brain cancer	0.000288	0.00285	CcSEcCtD
Dexamethasone—CYP1B1—pituitary gland—brain cancer	0.000287	0.00609	CbGeAlD
Dexamethasone—Haemoglobin—Hydroxyurea—brain cancer	0.000287	0.00284	CcSEcCtD
Dexamethasone—Haemorrhage—Hydroxyurea—brain cancer	0.000285	0.00282	CcSEcCtD
Dexamethasone—NR3C2—endocrine gland—brain cancer	0.000285	0.00603	CbGeAlD
Dexamethasone—Cardiac failure congestive—Etoposide—brain cancer	0.000284	0.00281	CcSEcCtD
Dexamethasone—Muscular weakness—Temozolomide—brain cancer	0.000284	0.00281	CcSEcCtD
Dexamethasone—Hallucination—Hydroxyurea—brain cancer	0.000284	0.00281	CcSEcCtD
Dexamethasone—Loss of consciousness—Procarbazine—brain cancer	0.000282	0.00279	CcSEcCtD
Dexamethasone—CYP17A1—brain—brain cancer	0.000282	0.00597	CbGeAlD
Dexamethasone—NR3C2—head—brain cancer	0.000281	0.00596	CbGeAlD
Dexamethasone—Convulsion—Procarbazine—brain cancer	0.000278	0.00275	CcSEcCtD
Dexamethasone—SLCO1A2—midbrain—brain cancer	0.000278	0.00589	CbGeAlD
Dexamethasone—Hypertension—Procarbazine—brain cancer	0.000277	0.00274	CcSEcCtD
Dexamethasone—Myalgia—Procarbazine—brain cancer	0.000273	0.0027	CcSEcCtD
Dexamethasone—NR3C1—brainstem—brain cancer	0.000273	0.00578	CbGeAlD
Dexamethasone—Anxiety—Procarbazine—brain cancer	0.000272	0.00269	CcSEcCtD
Dexamethasone—Sweating increased—Temozolomide—brain cancer	0.000271	0.00268	CcSEcCtD
Dexamethasone—SLCO1A2—spinal cord—brain cancer	0.000271	0.00575	CbGeAlD
Dexamethasone—CYP2A6—cerebellum—brain cancer	0.000267	0.00567	CbGeAlD
Dexamethasone—ABCB1—blood vessel—brain cancer	0.000267	0.00566	CbGeAlD
Dexamethasone—Anaphylactoid reaction—Etoposide—brain cancer	0.000266	0.00263	CcSEcCtD
Dexamethasone—PGR—endocrine gland—brain cancer	0.000265	0.00561	CbGeAlD
Dexamethasone—Cardiac failure—Etoposide—brain cancer	0.000264	0.00261	CcSEcCtD
Dexamethasone—ABCG2—telencephalon—brain cancer	0.000263	0.00557	CbGeAlD
Dexamethasone—Vomiting—Lomustine—brain cancer	0.000262	0.00259	CcSEcCtD
Dexamethasone—CYP11A1—brain—brain cancer	0.000262	0.00556	CbGeAlD
Dexamethasone—Oedema—Procarbazine—brain cancer	0.000262	0.00259	CcSEcCtD
Dexamethasone—PGR—head—brain cancer	0.000261	0.00554	CbGeAlD
Dexamethasone—Infection—Procarbazine—brain cancer	0.00026	0.00257	CcSEcCtD
Dexamethasone—Hyperglycaemia—Carmustine—brain cancer	0.00026	0.00257	CcSEcCtD
Dexamethasone—Angiopathy—Hydroxyurea—brain cancer	0.000259	0.00256	CcSEcCtD
Dexamethasone—Shock—Procarbazine—brain cancer	0.000258	0.00255	CcSEcCtD
Dexamethasone—Thrombocytopenia—Procarbazine—brain cancer	0.000256	0.00254	CcSEcCtD
Dexamethasone—NR3C2—central nervous system—brain cancer	0.000256	0.00544	CbGeAlD
Dexamethasone—Tachycardia—Procarbazine—brain cancer	0.000256	0.00253	CcSEcCtD
Dexamethasone—Weight increased—Temozolomide—brain cancer	0.000253	0.00251	CcSEcCtD
Dexamethasone—Hyperhidrosis—Procarbazine—brain cancer	0.000253	0.0025	CcSEcCtD
Dexamethasone—Alopecia—Hydroxyurea—brain cancer	0.000252	0.00249	CcSEcCtD
Dexamethasone—Weight decreased—Temozolomide—brain cancer	0.000252	0.00249	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Carmustine—brain cancer	0.000252	0.00249	CcSEcCtD
Dexamethasone—Hyperglycaemia—Temozolomide—brain cancer	0.000251	0.00248	CcSEcCtD
Dexamethasone—NR3C2—cerebellum—brain cancer	0.000251	0.00531	CbGeAlD
Dexamethasone—Anorexia—Procarbazine—brain cancer	0.00025	0.00247	CcSEcCtD
Dexamethasone—Erythema—Hydroxyurea—brain cancer	0.000248	0.00246	CcSEcCtD
Dexamethasone—Cardiac arrest—Etoposide—brain cancer	0.000245	0.00242	CcSEcCtD
Dexamethasone—Nausea—Lomustine—brain cancer	0.000245	0.00242	CcSEcCtD
Dexamethasone—Hypotension—Procarbazine—brain cancer	0.000245	0.00242	CcSEcCtD
Dexamethasone—SLCO1A2—endocrine gland—brain cancer	0.000244	0.00517	CbGeAlD
Dexamethasone—Neuropathy peripheral—Temozolomide—brain cancer	0.000243	0.00241	CcSEcCtD
Dexamethasone—NR3C1—telencephalon—brain cancer	0.000242	0.00513	CbGeAlD
Dexamethasone—SLCO1A2—head—brain cancer	0.000241	0.00511	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000239	0.00236	CcSEcCtD
Dexamethasone—PGR—central nervous system—brain cancer	0.000238	0.00505	CbGeAlD
Dexamethasone—CYP19A1—endocrine gland—brain cancer	0.000238	0.00505	CbGeAlD
Dexamethasone—Insomnia—Procarbazine—brain cancer	0.000237	0.00234	CcSEcCtD
Dexamethasone—Paraesthesia—Procarbazine—brain cancer	0.000235	0.00233	CcSEcCtD
Dexamethasone—CYP19A1—head—brain cancer	0.000235	0.00498	CbGeAlD
Dexamethasone—PGR—cerebellum—brain cancer	0.000233	0.00494	CbGeAlD
Dexamethasone—Haemoglobin—Carmustine—brain cancer	0.000232	0.00229	CcSEcCtD
Dexamethasone—Haemorrhage—Carmustine—brain cancer	0.000231	0.00228	CcSEcCtD
Dexamethasone—Ill-defined disorder—Hydroxyurea—brain cancer	0.00023	0.00228	CcSEcCtD
Dexamethasone—Hallucination—Carmustine—brain cancer	0.00023	0.00227	CcSEcCtD
Dexamethasone—Decreased appetite—Procarbazine—brain cancer	0.000228	0.00225	CcSEcCtD
Dexamethasone—CYP2E1—telencephalon—brain cancer	0.000227	0.00482	CbGeAlD
Dexamethasone—ABCC2—endocrine gland—brain cancer	0.000227	0.00482	CbGeAlD
Dexamethasone—Fatigue—Procarbazine—brain cancer	0.000226	0.00223	CcSEcCtD
Dexamethasone—Haemoglobin—Temozolomide—brain cancer	0.000224	0.00221	CcSEcCtD
Dexamethasone—Malaise—Hydroxyurea—brain cancer	0.000224	0.00221	CcSEcCtD
Dexamethasone—Pain—Procarbazine—brain cancer	0.000224	0.00221	CcSEcCtD
Dexamethasone—Haemorrhage—Temozolomide—brain cancer	0.000223	0.0022	CcSEcCtD
Dexamethasone—CYP1B1—endocrine gland—brain cancer	0.000223	0.00472	CbGeAlD
Dexamethasone—Visual impairment—Carmustine—brain cancer	0.000222	0.0022	CcSEcCtD
Dexamethasone—Hallucination—Temozolomide—brain cancer	0.000222	0.00219	CcSEcCtD
Dexamethasone—CYP2C8—pituitary gland—brain cancer	0.00022	0.00466	CbGeAlD
Dexamethasone—SLCO1A2—central nervous system—brain cancer	0.00022	0.00466	CbGeAlD
Dexamethasone—CYP1B1—head—brain cancer	0.00022	0.00466	CbGeAlD
Dexamethasone—CYP2A6—brain—brain cancer	0.000217	0.00461	CbGeAlD
Dexamethasone—Sweating increased—Etoposide—brain cancer	0.000217	0.00215	CcSEcCtD
Dexamethasone—Feeling abnormal—Procarbazine—brain cancer	0.000216	0.00213	CcSEcCtD
Dexamethasone—Eye disorder—Carmustine—brain cancer	0.000216	0.00213	CcSEcCtD
Dexamethasone—Convulsion—Hydroxyurea—brain cancer	0.000215	0.00213	CcSEcCtD
Dexamethasone—SLCO1A2—cerebellum—brain cancer	0.000215	0.00456	CbGeAlD
Dexamethasone—Visual impairment—Temozolomide—brain cancer	0.000215	0.00212	CcSEcCtD
Dexamethasone—CYP19A1—central nervous system—brain cancer	0.000215	0.00455	CbGeAlD
Dexamethasone—Gastrointestinal pain—Procarbazine—brain cancer	0.000214	0.00212	CcSEcCtD
Dexamethasone—ABCG2—pituitary gland—brain cancer	0.000214	0.00454	CbGeAlD
Dexamethasone—PTGS2—telencephalon—brain cancer	0.000209	0.00444	CbGeAlD
Dexamethasone—Discomfort—Hydroxyurea—brain cancer	0.000209	0.00207	CcSEcCtD
Dexamethasone—Eye disorder—Temozolomide—brain cancer	0.000208	0.00206	CcSEcCtD
Dexamethasone—Urticaria—Procarbazine—brain cancer	0.000208	0.00206	CcSEcCtD
Dexamethasone—Abdominal pain—Procarbazine—brain cancer	0.000207	0.00205	CcSEcCtD
Dexamethasone—Body temperature increased—Procarbazine—brain cancer	0.000207	0.00205	CcSEcCtD
Dexamethasone—ABCG2—medulla oblongata—brain cancer	0.000206	0.00438	CbGeAlD
Dexamethasone—Arrhythmia—Carmustine—brain cancer	0.000206	0.00204	CcSEcCtD
Dexamethasone—Alopecia—Carmustine—brain cancer	0.000204	0.00202	CcSEcCtD
Dexamethasone—NR3C2—brain—brain cancer	0.000204	0.00432	CbGeAlD
Dexamethasone—CYP2D6—brainstem—brain cancer	0.000203	0.0043	CbGeAlD
Dexamethasone—Oedema—Hydroxyurea—brain cancer	0.000203	0.002	CcSEcCtD
Dexamethasone—CYP2B6—gonad—brain cancer	0.000202	0.00429	CbGeAlD
Dexamethasone—Angiopathy—Temozolomide—brain cancer	0.000202	0.002	CcSEcCtD
Dexamethasone—NR3C1—gonad—brain cancer	0.000202	0.00428	CbGeAlD
Dexamethasone—Infection—Hydroxyurea—brain cancer	0.000201	0.00199	CcSEcCtD
Dexamethasone—Erythema—Carmustine—brain cancer	0.000201	0.00199	CcSEcCtD
Dexamethasone—CYP1B1—central nervous system—brain cancer	0.000201	0.00425	CbGeAlD
Dexamethasone—Nervous system disorder—Hydroxyurea—brain cancer	0.000199	0.00197	CcSEcCtD
Dexamethasone—Thrombocytopenia—Hydroxyurea—brain cancer	0.000198	0.00196	CcSEcCtD
Dexamethasone—NR3C1—pituitary gland—brain cancer	0.000197	0.00418	CbGeAlD
Dexamethasone—Alopecia—Temozolomide—brain cancer	0.000197	0.00195	CcSEcCtD
Dexamethasone—CYP1B1—cerebellum—brain cancer	0.000196	0.00416	CbGeAlD
Dexamethasone—Acute coronary syndrome—Etoposide—brain cancer	0.000196	0.00194	CcSEcCtD
Dexamethasone—CYP2C19—endocrine gland—brain cancer	0.000195	0.00414	CbGeAlD
Dexamethasone—Neuropathy peripheral—Etoposide—brain cancer	0.000195	0.00193	CcSEcCtD
Dexamethasone—Myocardial infarction—Etoposide—brain cancer	0.000195	0.00193	CcSEcCtD
Dexamethasone—Erythema—Temozolomide—brain cancer	0.000194	0.00192	CcSEcCtD
Dexamethasone—Anorexia—Hydroxyurea—brain cancer	0.000193	0.00191	CcSEcCtD
Dexamethasone—NR3C1—medulla oblongata—brain cancer	0.00019	0.00403	CbGeAlD
Dexamethasone—PGR—brain—brain cancer	0.000189	0.00401	CbGeAlD
Dexamethasone—ABCG2—midbrain—brain cancer	0.000189	0.004	CbGeAlD
Dexamethasone—Asthenia—Procarbazine—brain cancer	0.000188	0.00186	CcSEcCtD
Dexamethasone—Pruritus—Procarbazine—brain cancer	0.000185	0.00183	CcSEcCtD
Dexamethasone—ABCG2—spinal cord—brain cancer	0.000184	0.0039	CbGeAlD
Dexamethasone—CYP2D6—telencephalon—brain cancer	0.00018	0.00382	CbGeAlD
Dexamethasone—Ill-defined disorder—Temozolomide—brain cancer	0.00018	0.00178	CcSEcCtD
Dexamethasone—Diarrhoea—Procarbazine—brain cancer	0.000179	0.00177	CcSEcCtD
Dexamethasone—CYP2E1—medulla oblongata—brain cancer	0.000179	0.00379	CbGeAlD
Dexamethasone—Dyspepsia—Hydroxyurea—brain cancer	0.000178	0.00176	CcSEcCtD
Dexamethasone—Angioedema—Temozolomide—brain cancer	0.000177	0.00175	CcSEcCtD
Dexamethasone—Decreased appetite—Hydroxyurea—brain cancer	0.000176	0.00174	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000175	0.00173	CcSEcCtD
Dexamethasone—Malaise—Temozolomide—brain cancer	0.000175	0.00173	CcSEcCtD
Dexamethasone—Fatigue—Hydroxyurea—brain cancer	0.000175	0.00173	CcSEcCtD
Dexamethasone—SLCO1A2—brain—brain cancer	0.000175	0.0037	CbGeAlD
Dexamethasone—Vertigo—Temozolomide—brain cancer	0.000174	0.00172	CcSEcCtD
Dexamethasone—Convulsion—Carmustine—brain cancer	0.000174	0.00172	CcSEcCtD
Dexamethasone—NR3C1—midbrain—brain cancer	0.000174	0.00368	CbGeAlD
Dexamethasone—Hypertension—Carmustine—brain cancer	0.000173	0.00171	CcSEcCtD
Dexamethasone—Pain—Hydroxyurea—brain cancer	0.000173	0.00171	CcSEcCtD
Dexamethasone—Dizziness—Procarbazine—brain cancer	0.000173	0.00171	CcSEcCtD
Dexamethasone—Myalgia—Carmustine—brain cancer	0.000171	0.00169	CcSEcCtD
Dexamethasone—PTGS2—pituitary gland—brain cancer	0.000171	0.00362	CbGeAlD
Dexamethasone—CYP2C8—endocrine gland—brain cancer	0.00017	0.00361	CbGeAlD
Dexamethasone—Anxiety—Carmustine—brain cancer	0.00017	0.00168	CcSEcCtD
Dexamethasone—CYP19A1—brain—brain cancer	0.00017	0.00361	CbGeAlD
Dexamethasone—NR3C1—spinal cord—brain cancer	0.00017	0.0036	CbGeAlD
Dexamethasone—Convulsion—Temozolomide—brain cancer	0.000168	0.00166	CcSEcCtD
Dexamethasone—Hypertension—Temozolomide—brain cancer	0.000168	0.00166	CcSEcCtD
Dexamethasone—Feeling abnormal—Hydroxyurea—brain cancer	0.000167	0.00165	CcSEcCtD
Dexamethasone—Eye disorder—Etoposide—brain cancer	0.000167	0.00165	CcSEcCtD
Dexamethasone—Vomiting—Procarbazine—brain cancer	0.000167	0.00165	CcSEcCtD
Dexamethasone—Myalgia—Temozolomide—brain cancer	0.000165	0.00163	CcSEcCtD
Dexamethasone—Rash—Procarbazine—brain cancer	0.000165	0.00163	CcSEcCtD
Dexamethasone—Dermatitis—Procarbazine—brain cancer	0.000165	0.00163	CcSEcCtD
Dexamethasone—Anxiety—Temozolomide—brain cancer	0.000165	0.00163	CcSEcCtD
Dexamethasone—PTGS2—medulla oblongata—brain cancer	0.000165	0.00349	CbGeAlD
Dexamethasone—Headache—Procarbazine—brain cancer	0.000164	0.00162	CcSEcCtD
Dexamethasone—Oedema—Carmustine—brain cancer	0.000164	0.00162	CcSEcCtD
Dexamethasone—Discomfort—Temozolomide—brain cancer	0.000163	0.00161	CcSEcCtD
Dexamethasone—Infection—Carmustine—brain cancer	0.000163	0.00161	CcSEcCtD
Dexamethasone—Angiopathy—Etoposide—brain cancer	0.000162	0.0016	CcSEcCtD
Dexamethasone—Thrombocytopenia—Carmustine—brain cancer	0.00016	0.00159	CcSEcCtD
Dexamethasone—Body temperature increased—Hydroxyurea—brain cancer	0.00016	0.00158	CcSEcCtD
Dexamethasone—Tachycardia—Carmustine—brain cancer	0.00016	0.00158	CcSEcCtD
Dexamethasone—CYP2E1—spinal cord—brain cancer	0.000159	0.00338	CbGeAlD
Dexamethasone—CYP1B1—brain—brain cancer	0.000159	0.00338	CbGeAlD
Dexamethasone—Anaphylactic shock—Temozolomide—brain cancer	0.000158	0.00157	CcSEcCtD
Dexamethasone—Oedema—Temozolomide—brain cancer	0.000158	0.00157	CcSEcCtD
Dexamethasone—Alopecia—Etoposide—brain cancer	0.000158	0.00156	CcSEcCtD
Dexamethasone—Infection—Temozolomide—brain cancer	0.000157	0.00156	CcSEcCtD
Dexamethasone—CYP1A1—endocrine gland—brain cancer	0.000157	0.00334	CbGeAlD
Dexamethasone—Anorexia—Carmustine—brain cancer	0.000156	0.00154	CcSEcCtD
Dexamethasone—Nausea—Procarbazine—brain cancer	0.000156	0.00154	CcSEcCtD
Dexamethasone—CYP1A1—head—brain cancer	0.000155	0.00329	CbGeAlD
Dexamethasone—Nervous system disorder—Temozolomide—brain cancer	0.000155	0.00154	CcSEcCtD
Dexamethasone—Thrombocytopenia—Temozolomide—brain cancer	0.000155	0.00153	CcSEcCtD
Dexamethasone—CYP3A5—endocrine gland—brain cancer	0.000154	0.00326	CbGeAlD
Dexamethasone—Hypotension—Carmustine—brain cancer	0.000153	0.00151	CcSEcCtD
Dexamethasone—Hyperhidrosis—Temozolomide—brain cancer	0.000153	0.00151	CcSEcCtD
Dexamethasone—CYP2B6—endocrine gland—brain cancer	0.000153	0.00324	CbGeAlD
Dexamethasone—NR3C1—endocrine gland—brain cancer	0.000153	0.00324	CbGeAlD
Dexamethasone—CYP2C9—endocrine gland—brain cancer	0.000151	0.00321	CbGeAlD
Dexamethasone—Anorexia—Temozolomide—brain cancer	0.000151	0.00149	CcSEcCtD
Dexamethasone—CYP2B6—head—brain cancer	0.000151	0.0032	CbGeAlD
Dexamethasone—NR3C1—head—brain cancer	0.000151	0.0032	CbGeAlD
Dexamethasone—PTGS2—midbrain—brain cancer	0.00015	0.00319	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000149	0.00148	CcSEcCtD
Dexamethasone—Insomnia—Carmustine—brain cancer	0.000148	0.00147	CcSEcCtD
Dexamethasone—Paraesthesia—Carmustine—brain cancer	0.000147	0.00145	CcSEcCtD
Dexamethasone—PTGS2—spinal cord—brain cancer	0.000147	0.00311	CbGeAlD
Dexamethasone—ABCG2—cerebellum—brain cancer	0.000146	0.00309	CbGeAlD
Dexamethasone—Asthenia—Hydroxyurea—brain cancer	0.000145	0.00144	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000144	0.00143	CcSEcCtD
Dexamethasone—Ill-defined disorder—Etoposide—brain cancer	0.000144	0.00142	CcSEcCtD
Dexamethasone—CYP2E1—endocrine gland—brain cancer	0.000143	0.00304	CbGeAlD
Dexamethasone—Insomnia—Temozolomide—brain cancer	0.000143	0.00142	CcSEcCtD
Dexamethasone—Decreased appetite—Carmustine—brain cancer	0.000142	0.00141	CcSEcCtD
Dexamethasone—Paraesthesia—Temozolomide—brain cancer	0.000142	0.00141	CcSEcCtD
Dexamethasone—CYP1A1—central nervous system—brain cancer	0.000142	0.00301	CbGeAlD
Dexamethasone—CYP2E1—head—brain cancer	0.000142	0.003	CbGeAlD
Dexamethasone—Gastrointestinal disorder—Carmustine—brain cancer	0.000141	0.0014	CcSEcCtD
Dexamethasone—Pain—Carmustine—brain cancer	0.00014	0.00139	CcSEcCtD
Dexamethasone—Malaise—Etoposide—brain cancer	0.00014	0.00138	CcSEcCtD
Dexamethasone—Vertigo—Etoposide—brain cancer	0.00014	0.00138	CcSEcCtD
Dexamethasone—Dyspepsia—Temozolomide—brain cancer	0.000139	0.00138	CcSEcCtD
Dexamethasone—Diarrhoea—Hydroxyurea—brain cancer	0.000139	0.00137	CcSEcCtD
Dexamethasone—CYP2B6—central nervous system—brain cancer	0.000138	0.00292	CbGeAlD
Dexamethasone—Decreased appetite—Temozolomide—brain cancer	0.000138	0.00136	CcSEcCtD
Dexamethasone—NR3C1—central nervous system—brain cancer	0.000138	0.00292	CbGeAlD
Dexamethasone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000137	0.00135	CcSEcCtD
Dexamethasone—Fatigue—Temozolomide—brain cancer	0.000137	0.00135	CcSEcCtD
Dexamethasone—Loss of consciousness—Etoposide—brain cancer	0.000136	0.00135	CcSEcCtD
Dexamethasone—Pain—Temozolomide—brain cancer	0.000135	0.00134	CcSEcCtD
Dexamethasone—Feeling abnormal—Carmustine—brain cancer	0.000135	0.00134	CcSEcCtD
Dexamethasone—Convulsion—Etoposide—brain cancer	0.000135	0.00133	CcSEcCtD
Dexamethasone—NR3C1—cerebellum—brain cancer	0.000134	0.00285	CbGeAlD
Dexamethasone—Hypertension—Etoposide—brain cancer	0.000134	0.00133	CcSEcCtD
Dexamethasone—Dizziness—Hydroxyurea—brain cancer	0.000134	0.00133	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Carmustine—brain cancer	0.000134	0.00132	CcSEcCtD
Dexamethasone—PTGS2—endocrine gland—brain cancer	0.000132	0.0028	CbGeAlD
Dexamethasone—Discomfort—Etoposide—brain cancer	0.000131	0.00129	CcSEcCtD
Dexamethasone—Feeling abnormal—Temozolomide—brain cancer	0.000131	0.00129	CcSEcCtD
Dexamethasone—PTGS2—head—brain cancer	0.00013	0.00277	CbGeAlD
Dexamethasone—ABCB1—telencephalon—brain cancer	0.00013	0.00275	CbGeAlD
Dexamethasone—Abdominal pain—Carmustine—brain cancer	0.00013	0.00128	CcSEcCtD
Dexamethasone—Body temperature increased—Carmustine—brain cancer	0.00013	0.00128	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Temozolomide—brain cancer	0.00013	0.00128	CcSEcCtD
Dexamethasone—CYP2E1—central nervous system—brain cancer	0.000129	0.00274	CbGeAlD
Dexamethasone—Vomiting—Hydroxyurea—brain cancer	0.000129	0.00127	CcSEcCtD
Dexamethasone—Rash—Hydroxyurea—brain cancer	0.000128	0.00126	CcSEcCtD
Dexamethasone—Dermatitis—Hydroxyurea—brain cancer	0.000128	0.00126	CcSEcCtD
Dexamethasone—Headache—Hydroxyurea—brain cancer	0.000127	0.00126	CcSEcCtD
Dexamethasone—Anaphylactic shock—Etoposide—brain cancer	0.000127	0.00125	CcSEcCtD
Dexamethasone—CYP2E1—cerebellum—brain cancer	0.000126	0.00268	CbGeAlD
Dexamethasone—Infection—Etoposide—brain cancer	0.000126	0.00124	CcSEcCtD
Dexamethasone—Urticaria—Temozolomide—brain cancer	0.000126	0.00124	CcSEcCtD
Dexamethasone—Abdominal pain—Temozolomide—brain cancer	0.000125	0.00124	CcSEcCtD
Dexamethasone—Body temperature increased—Temozolomide—brain cancer	0.000125	0.00124	CcSEcCtD
Dexamethasone—Thrombocytopenia—Etoposide—brain cancer	0.000124	0.00123	CcSEcCtD
Dexamethasone—Tachycardia—Etoposide—brain cancer	0.000124	0.00122	CcSEcCtD
Dexamethasone—Hyperhidrosis—Etoposide—brain cancer	0.000123	0.00121	CcSEcCtD
Dexamethasone—CYP2C8—brain—brain cancer	0.000122	0.00259	CbGeAlD
Dexamethasone—Anorexia—Etoposide—brain cancer	0.000121	0.00119	CcSEcCtD
Dexamethasone—Nausea—Hydroxyurea—brain cancer	0.00012	0.00119	CcSEcCtD
Dexamethasone—PTGS2—central nervous system—brain cancer	0.000119	0.00252	CbGeAlD
Dexamethasone—ABCG2—brain—brain cancer	0.000119	0.00251	CbGeAlD
Dexamethasone—Hypotension—Etoposide—brain cancer	0.000118	0.00117	CcSEcCtD
Dexamethasone—Asthenia—Carmustine—brain cancer	0.000118	0.00116	CcSEcCtD
Dexamethasone—PTGS2—cerebellum—brain cancer	0.000116	0.00247	CbGeAlD
Dexamethasone—CYP3A4—endocrine gland—brain cancer	0.000115	0.00245	CbGeAlD
Dexamethasone—Paraesthesia—Etoposide—brain cancer	0.000114	0.00112	CcSEcCtD
Dexamethasone—Asthenia—Temozolomide—brain cancer	0.000114	0.00112	CcSEcCtD
Dexamethasone—CYP2D6—endocrine gland—brain cancer	0.000114	0.00241	CbGeAlD
Dexamethasone—CYP1A1—brain—brain cancer	0.000113	0.00239	CbGeAlD
Dexamethasone—CYP2D6—head—brain cancer	0.000112	0.00238	CbGeAlD
Dexamethasone—Diarrhoea—Carmustine—brain cancer	0.000112	0.00111	CcSEcCtD
Dexamethasone—Pruritus—Temozolomide—brain cancer	0.000112	0.00111	CcSEcCtD
Dexamethasone—Decreased appetite—Etoposide—brain cancer	0.00011	0.00109	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Etoposide—brain cancer	0.000109	0.00108	CcSEcCtD
Dexamethasone—CYP2B6—brain—brain cancer	0.000109	0.00232	CbGeAlD
Dexamethasone—Fatigue—Etoposide—brain cancer	0.000109	0.00108	CcSEcCtD
Dexamethasone—NR3C1—brain—brain cancer	0.000109	0.00232	CbGeAlD
Dexamethasone—Dizziness—Carmustine—brain cancer	0.000108	0.00107	CcSEcCtD
Dexamethasone—Pain—Etoposide—brain cancer	0.000108	0.00107	CcSEcCtD
Dexamethasone—Diarrhoea—Temozolomide—brain cancer	0.000108	0.00107	CcSEcCtD
Dexamethasone—ABCB1—gonad—brain cancer	0.000108	0.00229	CbGeAlD
Dexamethasone—ABCB1—pituitary gland—brain cancer	0.000105	0.00224	CbGeAlD
Dexamethasone—Dizziness—Temozolomide—brain cancer	0.000105	0.00104	CcSEcCtD
Dexamethasone—Feeling abnormal—Etoposide—brain cancer	0.000104	0.00103	CcSEcCtD
Dexamethasone—Vomiting—Carmustine—brain cancer	0.000104	0.00103	CcSEcCtD
Dexamethasone—CYP3A4—central nervous system—brain cancer	0.000104	0.00221	CbGeAlD
Dexamethasone—Gastrointestinal pain—Etoposide—brain cancer	0.000104	0.00102	CcSEcCtD
Dexamethasone—Rash—Carmustine—brain cancer	0.000103	0.00102	CcSEcCtD
Dexamethasone—Dermatitis—Carmustine—brain cancer	0.000103	0.00102	CcSEcCtD
Dexamethasone—Headache—Carmustine—brain cancer	0.000103	0.00101	CcSEcCtD
Dexamethasone—CYP2E1—brain—brain cancer	0.000103	0.00218	CbGeAlD
Dexamethasone—CYP2D6—central nervous system—brain cancer	0.000102	0.00217	CbGeAlD
Dexamethasone—ABCB1—medulla oblongata—brain cancer	0.000102	0.00216	CbGeAlD
Dexamethasone—Vomiting—Temozolomide—brain cancer	0.000101	0.000995	CcSEcCtD
Dexamethasone—Urticaria—Etoposide—brain cancer	0.000101	0.000995	CcSEcCtD
Dexamethasone—Abdominal pain—Etoposide—brain cancer	0.0001	0.00099	CcSEcCtD
Dexamethasone—Body temperature increased—Etoposide—brain cancer	0.0001	0.00099	CcSEcCtD
Dexamethasone—CYP2D6—cerebellum—brain cancer	0.0001	0.00212	CbGeAlD
Dexamethasone—Rash—Temozolomide—brain cancer	9.99e-05	0.000987	CcSEcCtD
Dexamethasone—Dermatitis—Temozolomide—brain cancer	9.98e-05	0.000986	CcSEcCtD
Dexamethasone—Headache—Temozolomide—brain cancer	9.92e-05	0.000981	CcSEcCtD
Dexamethasone—Nausea—Carmustine—brain cancer	9.73e-05	0.000962	CcSEcCtD
Dexamethasone—PTGS2—brain—brain cancer	9.45e-05	0.002	CbGeAlD
Dexamethasone—Nausea—Temozolomide—brain cancer	9.41e-05	0.00093	CcSEcCtD
Dexamethasone—ABCB1—midbrain—brain cancer	9.3e-05	0.00197	CbGeAlD
Dexamethasone—Asthenia—Etoposide—brain cancer	9.09e-05	0.000899	CcSEcCtD
Dexamethasone—ABCB1—spinal cord—brain cancer	9.08e-05	0.00192	CbGeAlD
Dexamethasone—Pruritus—Etoposide—brain cancer	8.97e-05	0.000886	CcSEcCtD
Dexamethasone—Diarrhoea—Etoposide—brain cancer	8.67e-05	0.000857	CcSEcCtD
Dexamethasone—Dizziness—Etoposide—brain cancer	8.38e-05	0.000828	CcSEcCtD
Dexamethasone—ABCB1—endocrine gland—brain cancer	8.17e-05	0.00173	CbGeAlD
Dexamethasone—CYP2D6—brain—brain cancer	8.13e-05	0.00172	CbGeAlD
Dexamethasone—ABCB1—head—brain cancer	8.07e-05	0.00171	CbGeAlD
Dexamethasone—Vomiting—Etoposide—brain cancer	8.06e-05	0.000797	CcSEcCtD
Dexamethasone—Rash—Etoposide—brain cancer	7.99e-05	0.00079	CcSEcCtD
Dexamethasone—Dermatitis—Etoposide—brain cancer	7.98e-05	0.000789	CcSEcCtD
Dexamethasone—Headache—Etoposide—brain cancer	7.94e-05	0.000785	CcSEcCtD
Dexamethasone—Nausea—Etoposide—brain cancer	7.53e-05	0.000744	CcSEcCtD
Dexamethasone—ABCB1—central nervous system—brain cancer	7.36e-05	0.00156	CbGeAlD
Dexamethasone—ABCB1—cerebellum—brain cancer	7.2e-05	0.00153	CbGeAlD
Dexamethasone—ABCB1—brain—brain cancer	5.85e-05	0.00124	CbGeAlD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.51e-05	0.000249	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—IDH1—brain cancer	2.5e-05	0.000248	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.5e-05	0.000247	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	2.5e-05	0.000247	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—GLI2—brain cancer	2.49e-05	0.000246	CbGpPWpGaD
Dexamethasone—NOS2—Disease—VAV1—brain cancer	2.4e-05	0.000238	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—PIK3CG—brain cancer	2.4e-05	0.000238	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.39e-05	0.000237	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	2.36e-05	0.000234	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	2.36e-05	0.000233	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—NOTCH2—brain cancer	2.34e-05	0.000232	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—GLI1—brain cancer	2.34e-05	0.000231	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—STAT3—brain cancer	2.32e-05	0.00023	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.32e-05	0.00023	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—MYC—brain cancer	2.32e-05	0.000229	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—DNMT1—brain cancer	2.32e-05	0.000229	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	2.3e-05	0.000228	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—CYP2C9—brain cancer	2.29e-05	0.000227	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—IL2—brain cancer	2.26e-05	0.000224	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.25e-05	0.000223	CbGpPWpGaD
Dexamethasone—NR3C2—Generic Transcription Pathway—MYC—brain cancer	2.24e-05	0.000221	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—VAV1—brain cancer	2.23e-05	0.000221	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.23e-05	0.000221	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—IDH1—brain cancer	2.22e-05	0.00022	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—IL2—brain cancer	2.22e-05	0.00022	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.22e-05	0.000219	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SUFU—brain cancer	2.22e-05	0.000219	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—IL2—brain cancer	2.21e-05	0.000218	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—CYP2C9—brain cancer	2.21e-05	0.000218	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—CCND1—brain cancer	2.2e-05	0.000218	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—ENO2—brain cancer	2.19e-05	0.000216	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.18e-05	0.000216	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.17e-05	0.000215	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	2.17e-05	0.000215	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.17e-05	0.000214	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—BSG—brain cancer	2.16e-05	0.000213	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.15e-05	0.000213	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—GFAP—brain cancer	2.14e-05	0.000212	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	2.12e-05	0.00021	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—ESR2—brain cancer	2.08e-05	0.000206	CbGpPWpGaD
Dexamethasone—NOS2—Disease—HES1—brain cancer	2.07e-05	0.000205	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.06e-05	0.000204	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.05e-05	0.000203	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.04e-05	0.000202	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HEY1—brain cancer	2.03e-05	0.000201	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.03e-05	0.000201	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CYP2C9—brain cancer	2.01e-05	0.000199	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—ENO2—brain cancer	2e-05	0.000198	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2e-05	0.000198	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CYP2C9—brain cancer	1.99e-05	0.000197	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—DLL1—brain cancer	1.99e-05	0.000197	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HES5—brain cancer	1.99e-05	0.000197	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—ENO2—brain cancer	1.98e-05	0.000196	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—NOTCH2—brain cancer	1.97e-05	0.000195	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PDGFRA—brain cancer	1.97e-05	0.000195	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—BSG—brain cancer	1.95e-05	0.000193	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—HES1—brain cancer	1.92e-05	0.00019	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.9e-05	0.000188	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—VEGFA—brain cancer	1.89e-05	0.000187	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—BSG—brain cancer	1.88e-05	0.000186	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.88e-05	0.000186	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—IL2—brain cancer	1.86e-05	0.000184	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—IDH1—brain cancer	1.85e-05	0.000184	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PDGFRA—brain cancer	1.83e-05	0.000181	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.83e-05	0.000181	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CYP2C9—brain cancer	1.82e-05	0.000181	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.81e-05	0.000179	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	1.78e-05	0.000176	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—SPP1—brain cancer	1.77e-05	0.000176	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—MYC—brain cancer	1.77e-05	0.000175	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—ENO2—brain cancer	1.76e-05	0.000174	CbGpPWpGaD
Dexamethasone—NOS2—Disease—IRS2—brain cancer	1.73e-05	0.000171	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—EGFR—brain cancer	1.73e-05	0.000171	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—BSG—brain cancer	1.71e-05	0.000169	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.7e-05	0.000168	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—BSG—brain cancer	1.69e-05	0.000168	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SHH—brain cancer	1.69e-05	0.000167	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—IL2—brain cancer	1.69e-05	0.000167	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—IDH1—brain cancer	1.68e-05	0.000166	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—SIRT1—brain cancer	1.67e-05	0.000166	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.66e-05	0.000165	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—PIK3CG—brain cancer	1.66e-05	0.000165	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.64e-05	0.000163	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TRPC6—brain cancer	1.63e-05	0.000161	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—IDH1—brain cancer	1.61e-05	0.00016	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IRS2—brain cancer	1.61e-05	0.000159	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SMO—brain cancer	1.6e-05	0.000159	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PTCH1—brain cancer	1.6e-05	0.000159	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—BSG—brain cancer	1.55e-05	0.000154	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.55e-05	0.000153	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CYP2C9—brain cancer	1.53e-05	0.000152	CbGpPWpGaD
Dexamethasone—NOS2—Disease—APC—brain cancer	1.53e-05	0.000151	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.51e-05	0.000149	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.5e-05	0.000148	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.48e-05	0.000147	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CYP2C9—brain cancer	1.47e-05	0.000146	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—IDH1—brain cancer	1.47e-05	0.000145	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ENO2—brain cancer	1.47e-05	0.000145	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—IDH1—brain cancer	1.46e-05	0.000144	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TP53—brain cancer	1.45e-05	0.000144	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CYP2C9—brain cancer	1.44e-05	0.000143	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CYP2C9—brain cancer	1.44e-05	0.000142	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—TP53—brain cancer	1.43e-05	0.000141	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—APC—brain cancer	1.42e-05	0.00014	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PIK3CG—brain cancer	1.42e-05	0.00014	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—MYC—brain cancer	1.41e-05	0.00014	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.36e-05	0.000135	CbGpPWpGaD
Dexamethasone—PGR—Generic Transcription Pathway—MYC—brain cancer	1.36e-05	0.000135	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CYP2C9—brain cancer	1.36e-05	0.000135	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—DNMT1—brain cancer	1.34e-05	0.000133	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IDH1—brain cancer	1.34e-05	0.000132	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—IDH1—brain cancer	1.33e-05	0.000132	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ENO2—brain cancer	1.32e-05	0.000131	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.31e-05	0.00013	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PIK3CG—brain cancer	1.31e-05	0.00013	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.31e-05	0.000129	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—BSG—brain cancer	1.3e-05	0.000129	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.29e-05	0.000128	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—EGFR—brain cancer	1.29e-05	0.000128	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NOTCH2—brain cancer	1.28e-05	0.000127	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ENO2—brain cancer	1.28e-05	0.000126	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HEY1—brain cancer	1.27e-05	0.000125	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—BSG—brain cancer	1.25e-05	0.000124	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CYP2C9—brain cancer	1.25e-05	0.000123	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—DLL1—brain cancer	1.24e-05	0.000123	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—BSG—brain cancer	1.23e-05	0.000121	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—BSG—brain cancer	1.22e-05	0.000121	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VAV1—brain cancer	1.22e-05	0.000121	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—ESR2—brain cancer	1.2e-05	0.000119	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.2e-05	0.000119	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.2e-05	0.000119	CbGpPWpGaD
Dexamethasone—NOS2—Disease—ERBB2—brain cancer	1.19e-05	0.000117	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.18e-05	0.000116	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ENO2—brain cancer	1.16e-05	0.000115	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—BSG—brain cancer	1.16e-05	0.000114	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ENO2—brain cancer	1.15e-05	0.000114	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—NOTCH2—brain cancer	1.14e-05	0.000113	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—IDH1—brain cancer	1.12e-05	0.000111	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP2C9—brain cancer	1.11e-05	0.00011	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—RELA—brain cancer	1.11e-05	0.00011	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—ERBB2—brain cancer	1.1e-05	0.000109	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CYP2C9—brain cancer	1.09e-05	0.000107	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—MYC—brain cancer	1.08e-05	0.000107	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—IDH1—brain cancer	1.08e-05	0.000107	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.06e-05	0.000105	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—BSG—brain cancer	1.06e-05	0.000105	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ENO2—brain cancer	1.06e-05	0.000105	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SHH—brain cancer	1.06e-05	0.000105	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ENO2—brain cancer	1.05e-05	0.000104	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—IDH1—brain cancer	1.05e-05	0.000104	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—IDH1—brain cancer	1.05e-05	0.000104	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.05e-05	0.000104	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HES1—brain cancer	1.05e-05	0.000104	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CTNNB1—brain cancer	1.04e-05	0.000103	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP2C9—brain cancer	1.02e-05	0.000101	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PIK3CG—brain cancer	1e-05	9.93e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PDGFRA—brain cancer	1e-05	9.9e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IL2—brain cancer	9.98e-06	9.88e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—IDH1—brain cancer	9.94e-06	9.84e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	9.87e-06	9.77e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCND1—brain cancer	9.72e-06	9.63e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SPP1—brain cancer	9.7e-06	9.61e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—SIRT1—brain cancer	9.68e-06	9.58e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CTNNB1—brain cancer	9.63e-06	9.53e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—BSG—brain cancer	9.46e-06	9.36e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	9.26e-06	9.16e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—BSG—brain cancer	9.23e-06	9.14e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PIK3CG—brain cancer	9.17e-06	9.08e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.12e-06	9.03e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—IDH1—brain cancer	9.11e-06	9.02e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PIK3CG—brain cancer	9.08e-06	8.99e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—STAT3—brain cancer	9.04e-06	8.95e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ENO2—brain cancer	8.85e-06	8.76e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IRS2—brain cancer	8.78e-06	8.69e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—BSG—brain cancer	8.7e-06	8.61e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—BSG—brain cancer	8.62e-06	8.54e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	8.52e-06	8.43e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ENO2—brain cancer	8.51e-06	8.42e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—VEGFA—brain cancer	8.48e-06	8.39e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—MYC—brain cancer	8.4e-06	8.32e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—STAT3—brain cancer	8.39e-06	8.31e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ENO2—brain cancer	8.33e-06	8.25e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	8.33e-06	8.25e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ENO2—brain cancer	8.31e-06	8.23e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—EGFR—brain cancer	8.22e-06	8.14e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—IDH1—brain cancer	8.13e-06	8.05e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.09e-06	8.01e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PIK3CG—brain cancer	8.05e-06	7.97e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—IDH1—brain cancer	7.94e-06	7.86e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—MYC—brain cancer	7.87e-06	7.8e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ENO2—brain cancer	7.86e-06	7.78e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MYC—brain cancer	7.8e-06	7.72e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—APC—brain cancer	7.75e-06	7.67e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PIK3CG—brain cancer	7.75e-06	7.67e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—VAV1—brain cancer	7.64e-06	7.56e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—EGFR—brain cancer	7.63e-06	7.55e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—IDH1—brain cancer	7.48e-06	7.4e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.42e-06	7.34e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—IDH1—brain cancer	7.41e-06	7.34e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ENO2—brain cancer	7.2e-06	7.13e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.99e-06	6.92e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CG—brain cancer	6.72e-06	6.66e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP2C9—brain cancer	6.69e-06	6.62e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.62e-06	6.56e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HES1—brain cancer	6.57e-06	6.5e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—MYC—brain cancer	6.56e-06	6.49e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ENO2—brain cancer	6.43e-06	6.36e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—brain cancer	6.41e-06	6.34e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ENO2—brain cancer	6.27e-06	6.21e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PDGFRA—brain cancer	6.25e-06	6.19e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CG—brain cancer	6.08e-06	6.02e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RELA—brain cancer	6.06e-06	6e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.04e-06	5.98e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ERBB2—brain cancer	6.02e-06	5.96e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ENO2—brain cancer	5.91e-06	5.85e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ENO2—brain cancer	5.86e-06	5.8e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CG—brain cancer	5.85e-06	5.79e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—BSG—brain cancer	5.69e-06	5.63e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IRS2—brain cancer	5.49e-06	5.43e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL2—brain cancer	5.45e-06	5.4e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CG—brain cancer	5.32e-06	5.27e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCND1—brain cancer	5.32e-06	5.26e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CG—brain cancer	5.28e-06	5.22e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CTNNB1—brain cancer	5.27e-06	5.21e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—IDH1—brain cancer	4.89e-06	4.84e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—APC—brain cancer	4.85e-06	4.8e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CG—brain cancer	4.84e-06	4.79e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—brain cancer	4.64e-06	4.59e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—STAT3—brain cancer	4.59e-06	4.54e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYC—brain cancer	4.26e-06	4.22e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—brain cancer	4.17e-06	4.13e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CG—brain cancer	4.06e-06	4.02e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CG—brain cancer	3.9e-06	3.86e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ENO2—brain cancer	3.87e-06	3.83e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CG—brain cancer	3.82e-06	3.78e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CG—brain cancer	3.81e-06	3.78e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—brain cancer	3.79e-06	3.75e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ERBB2—brain cancer	3.76e-06	3.73e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CG—brain cancer	3.6e-06	3.57e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—brain cancer	3.5e-06	3.47e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CG—brain cancer	3.3e-06	3.27e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CTNNB1—brain cancer	3.29e-06	3.26e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CG—brain cancer	2.95e-06	2.92e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CG—brain cancer	2.88e-06	2.85e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—brain cancer	2.87e-06	2.84e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CG—brain cancer	2.71e-06	2.69e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CG—brain cancer	2.69e-06	2.66e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—brain cancer	2.67e-06	2.64e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—brain cancer	2.61e-06	2.58e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CG—brain cancer	1.77e-06	1.76e-05	CbGpPWpGaD
